Delivery Order SPE2DB22D3501-SPE2DB25FTR33

Award Date 12/2/24
Potential Completion Date 12/3/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,073.02 firm fixed-price delivery order is for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a pharmaceutical product, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,959.52 firm-fixed-price delivery order is for the supply of CEFAZOLIN 1 G/50 ML-DEXTROSES, a medical product, with an ultimate completion date of October 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,307.25 firm-fixed-price delivery order is for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a pharmaceutical product, with a period of performance through October 30, 2024. The award is not designated as a set-aside contract. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $1,445.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4565584696 - CEFAZOLIN 2 G/50 ML-DEXTROSES, a critical medical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,380.80 firm-fixed-price delivery order contract is for the supply of 4566489160 CEFAZOLIN 2 G/50 ML-DEXTROSES, a pharmaceutical product. The award has an ultimate completion date of November 20, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,532.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a pharmaceutical product. The contract is not designated as a set-aside and has an ultimate completion date of January 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,082.20 firm fixed-price delivery order contract is for the supply of Cefazolin 2 g/50 ml-dextrose, a critical antibiotic medication. The award is part of a larger Indefinite Delivery Contract (IDC) vehicle, valued at $999,999,999, that Amerisourcebergen holds with the DLA Troop Support Medical for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,904.77 delivery order is for the supply of CEFAZOLIN 1 G/50 ML-DEXTROSES, a critical care pharmaceutical product, with a performance period ending on July 23, 2024. The contract is a Firm Fixed Price (FFP) delivery order, without any set-aside designation. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,161.82 firm fixed-price delivery order contract is for the supply of Cefazolin 2 g/50 ml-dextroses, a critical medical commodity. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,503.50 Firm Fixed Price Delivery Order is for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024 and was awarded on November 15, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FTR33
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,457.12 firm fixed-price delivery order is for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a medical product used in healthcare settings.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses critical medical commodities across multiple therapeutic areas.

The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, with no major subcontractors noted. The award supports the DLA's mission of providing medical products and supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 4/1/25, 2:42 PM